Please Wait.....
Report
Global Diabetes Devices and Therapeutics Business Investment Opportunities - Analysis and Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape - Q2 2023 Update
Market Report I 2023-01-05 I 1350 Pages I BioIntel360
Insights and data in the report have been segmented under the following six modules:
Module 1: Global Diabetes Devices & Therapeutics Investment Landscape
This module provides insights and data related to diabetes devices & therapeutics partnerships and investment (research and development, mergers and acquisitions, product development, commercialization, licensing, and manufacturing) and allows a peek into the futuristic trends of diabetes devices & therapeutics technology investment area.
Module 2: Global Diabetes Devices & Therapeutics Clinical Trial Data Assessment
This module evaluates the data available from clinical trials related to diabetes devices & therapeutics, representing a bird's eye view of emerging market dynamics and risks in the diabetes devices & therapeutics sector.
Module 3: Global Diabetes Devices & Therapeutics Patent Data Analysis
This module presents an exhaustive study of diabetes devices & therapeutics patent analytics at various levels, including strategic research planning as well as analyzing their potential applications.
Module 4: Competitive Landscape
This module provides detailed information along with a scoring matrix of key companies related to the diabetes devices & therapeutics industry, including their historical performance and the latest developments.
Module 5: Global diabetes devices & therapeutics Market Size and Forecast
This module provides projections on the market's development during the years 2018-2027 after the profound evaluation of market dynamics at the deeper segmentation level. This report also provides an in-depth, data-centric analysis of the global diabetes devices & therapeutics market at regional and country levels:
Diabetes Devices and Therapeutics Market Share by Category
- Diagnosis and Monitoring Devices
- Therapeutics
Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices
- Blood Glucose Monitoring Devices
- Insulin Delivery Devices
- Diabetes Management and Mobile Applications
- Artificial Pancreas Devices
Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices
- Self-Monitoring Blood Glucose Devices
- Continuous Blood Glucose Monitoring Devices
- Test Strips
- Lancets
Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices
- Insulin Pumps
- Insulin Pens
- Insulin Syringes
Diabetes Devices and Therapeutics Market Share by Therapeutics
- Oral Anti-Diabetic Drugs
- Insulin
- Non-Insulin Injectable Drugs
- Combination Drugs
Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs
- Alpha-Glucosidase Inhibitors
- DPP-4 Inhibitors
- SGLT-2 Inhibitors
Diabetes Devices and Therapeutics Market Share by Insulin
- Basal or Long-Acting
- Bolus or Fast-Acting
- Traditional Human Insulin Drugs
- Insulin Biosimilars
Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs
- GLP-1 Receptor Agonists
- Amylin Analogue
Diabetes Devices and Therapeutics Market Share by Combination Drugs
- Combination Insulin
- Oral Combination
Diabetes Devices and Therapeutics Market Share by Route of Administration
- Subcutaneous
- Intravenous
- Others
Diabetes Devices and Therapeutics Market Share by Type of Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
Diabetes Devices and Therapeutics Market Share by Distribution Channels
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Diabetes Devices and Therapeutics Market Share by End User
- Hospitals
- Diabetes Clinics
- Homecare
Diabetes Devices & Therapeutics Market Size By Regions
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Germany
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- Australia
- India
- South Korea
- MEA region
- Israel
- South Africa
- Turkey
- Saudi Arabia
- Latin America
- Brazil
- Argentina
- Colombia
Key Companies Covered
- Abbott
- Eli Lilly and Company
- Sanofi
- Johnson & Johnson
- Roche Diagnostics
- AstraZeneca
- Novo Nordisk
- Tandem Diabetes Care
- Novartis
- Medtronic Plc
Module 6 Regulatory Outlook
This module contains a detailed understanding of the ethical, legal, and social implications of diabetes devices & therapeutics.
This market intelligence report features an in-depth analysis on the current market dynamics of the diabetes devices and therapeutics market.
It provides a detailed analysis of diabetes devices and therapeutics market dynamics, covering clinical trials, patent data, financial deals, and competitive landscape through 35 sections, 700+ tables, and 1000+ charts.
Chapter 1 About this Report
1.1 Research Methodology
1.2 Definitions
1.3 Disclaimer
Chapter 2 Global Diabetes Devices and Therapeutics Market Outlook and Future Growth Dynamics
2.1 Introduction
2.2 Market Opportunities and Growth Dynamics
2.3 Strategy and Innovations
2.4 Regulation and Challenges Related to Diabetes Devices and Therapeutics Around the Globe
Chapter 3 Regulatory Dynamics Assessment Across Different Regions
3.1 North America Diabetes Devices and Therapeutics Regulations
3.2 Europe Diabetes Devices and Therapeutics Regulations
3.3 Asia Pacific Diabetes Devices and Therapeutics Regulations
3.4 Latin America Diabetes Devices and Therapeutics Regulations
3.5 Middle East & Africa Region Diabetes Devices and Therapeutics Regulation
Chapter 4 Global Diabetes Prevalence and Regional Distribution
4.1 List of Top Diabetes Drugs Sales in 2020 and Expected Sales in 2024
4.2 Diabetes Percentage of Diabetics in the Global Adult Population in 2021, 2030, and 2045
4.3 Number of Adults (20-79 years) with Diabetes per World Bank Income Classification in 2021 and 2045
4.4 Number of People with Diabetes in Adults (20-79 years) by Age Group in 2021 and Estimated Prevalence Across Age Groups in 2045
4.5 Top 10 Countries or Territories for Number of Adults (20-79 years) with Diabetes in 2021 and 2045
4.6 Total Diabetes-Related Health Expenditure for Adults (20-79 years) with Diabetes from 2006 to 2045
4.7 List of Countries or Territories with the Highest Total Health Expenditure (USD Billion) Due to Diabetes (20-79 years) in 2022
4.8 Diabetes Prevalence (%) by Regional Distribution in 2021
4.9 List of Top Selling FDA Approved Diabetes Drugs
4.10 Top FDA Approved in Diabetes Care From the First Half of 2022
Chapter 5 Global Diabetes Devices and Therapeutics Financial Deals & Alliances Market Dynamics & Outlook
5.1 Diabetes Devices and Therapeutics Financial Deals & Alliances Market Prediction and Estimation
5.2 Diabetes Devices and Therapeutics Partnerships Vs Mergers & Acquisition, 2022 vs 2025
5.3 Diabetes Devices and Therapeutics Financial Deals Analysis by Category, 2022 vs 2025
5.4 Diabetes Devices and Therapeutics Financial Deals Analysis by Types of Diabetes, 2022 vs 2025
5.5 Diabetes Devices and Therapeutics Financial Deals Analysis by Phase-Wise Deals, 2022 vs 2025
5.6 Diabetes Devices and Therapeutics Financial Deals Analysis by Type of Industry, 2022 vs 2025
5.7 Diabetes Devices and Therapeutics Financial Deals Analysis by Region, 2022 vs 2025
5.8 Diabetes Devices and Therapeutics Financial Deals Analysis by Funding Type, 2018-2022
5.9 Diabetes Devices and Therapeutics Financial Deals Analysis by Funding Stage, 2018-2022
5.10 Number of Diabetes Devices and Therapeutics in Clinical Stage, 2018-2022
5.11 Recent Deals and Partnership of Diabetes Devices and Therapeutics
5.12 Recent Diabetes Devices and Therapeutics Mergers and Acquisitions
5.13 Global Diabetes Devices and Therapeutics Deals Landscape, 2020-2022
Chapter 6 Global Diabetes Devices and Therapeutics Patent Analysis & Outlook
6.1 Diabetes Devices and Therapeutics Historical and Futuristic Trend of Patent, 2018-2027
6.2 Diabetes Devices Historical and Futuristic Trend of Patent, 2018-2027
6.3 Diabetes Therapeutics Historical and Futuristic Trend of Patent, 2018-2027
6.4 Diabetes Devices and Therapeutics Patent Analysis by Type of Diabetes Therapeutics Players, 2022 vs 2025
6.5 Diabetes Devices and Therapeutics Patent Analysis by Type of Diabetes Devices, 2022 vs 2025
6.6 Diabetes Therapeutics Patent Analysis by Patent Type, 2018-2022
6.7 Diabetes Devices Patent Analysis by Patent Type, 2018-2022
6.8 Diabetes Therapeutics Patent Analysis by Legal Status, 2018-2022
6.9 Diabetes Devices Patent Analysis by Legal Status, 2018-2022
6.10 Diabetes Therapeutics Patent Analysis by Top Patent Owners
6.11 Diabetes Devices Patent Analysis by Top Patent Owners
6.12 Diabetes Therapeutics Patent Analysis by Top Patent Applicants
6.13 Diabetes Devices Patent Analysis by Top Patent Applicants
6.14 Diabetes Devices and Therapeutics: Diabetes Therapeutics Top Patent Applicants Benchmarking Analysis
6.15 Diabetes Devices and Therapeutics: Diabetes Devices Key Patent Applicant Benchmarking Analysis
6.16 Diabetes Therapeutics Patent Analysis by Published Status
6.17 Diabetes Devices Patent Analysis by Published Status
6.18 Diabetes Therapeutics Patent Analysis by Investors
6.19 Diabetes Devices Patent Analysis by Investors
6.20 Diabetes Therapeutics Patent Analysis by CPC Classification Code
6.21 Diabetes Devices Patent Analysis by CPC Classification Code
6.22 Diabetes Therapeutics Patent Documents by Jurisdiction
6.23 Diabetes Devices Patent Documents by Jurisdiction
6.24 List of Recent Diabetes Therapeutics Patents
6.25 List of Recent Diabetes Devices Patents
Chapter 7 Diabetes Devices and Therapeutics Clinical Trial Analysis & Outlook
7.1 Diabetes Devices and Therapeutics Clinical Trial Historical and Futuristics Trend
7.2 Diabetes Therapeutics Clinical Trial Region-wise Prediction & Estimation, 2018-2027
7.3 Diabetes Devices Clinical Trial Region-wise Prediction & Estimation, 2018-2027
7.4 Diabetes Therapeutics Clinical Trial Analysis by Country-wise Analysis
7.5 Diabetes Devices Clinical Trial Analysis by Country-wise
7.6 Diabetes Devices and Therapeutics Clinical Trial Analysis by Age Group
7.7 Diabetes Devices and Therapeutics Clinical Trial Analysis by Funding Agency
7.8 Diabetes Devices and Therapeutics Clinical Trial Analysis by Documents
7.9 Diabetes Devices and Therapeutics Clinical Trial Analysis by Phase-wise
7.10 Diabetes Devices and Therapeutics Clinical Trial Analysis by Status
7.11 Diabetes Devices and Therapeutics Clinical Trial Analysis by Study Type
Chapter 8 Diabetes Devices and Therapeutics Competitive Landscape Analysis: Key Company Profiles and Strategic Initiatives
8.1 Diabetes Devices and Therapeutics Competitive Index Ranking & Attractiveness Quadrant
8.2 Diabetes Devices and Therapeutics Company Market Share
8.3 Diabetes Devices and Therapeutics Competitive Mapping Quadrant
8.4 Diabetes Devices and Therapeutics Competitive Landscape by End Markets
8.5 Key Companies by Regions
8.6 Competitive Landscape by Category of Diabetes Devices and Therapeutics
8.7 Abbott
8.8 Eli Lilly and Company
8.9 Sanofi
8.10 Johnson & Johnson
8.11 Roche Diagnostics
8.12 AstraZeneca
8.13 Novo Nordisk
8.14 Tandem Diabetes Care
8.15 Novartis
8.16 Medtronic Plc
Chapter 9 Global Diabetes Devices and Therapeutics Market Size and Forecast, 2018-2027
9.1 Global Diabetes Devices and Therapeutics Market Share by Category, 2018-2027
9.1.1 Global Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2018-2027
9.1.2 Global Diabetes Devices and Therapeutics Market Size by Therapeutics, 2018-2027
9.2 Global Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2018-2027
9.2.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2018-2027
9.2.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2018-2027
9.2.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2018-2027
9.2.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2018-2027
9.3 Global Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2018-2027
9.3.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2018-2027
9.3.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2018-2027
9.3.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2018-2027
9.3.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2018-2027
9.4 Global Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2018-2027
9.4.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2018-2027
9.4.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2018-2027
9.4.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2018-2027
9.5 Global Diabetes Devices and Therapeutics Market Share by Therapeutics, 2018-2027
9.5.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2018-2027
9.5.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2018-2027
9.5.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2018-2027
9.5.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2018-2027
9.6 Global Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2018-2027
9.6.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2018-2027
9.6.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2018-2027
9.6.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2018-2027
9.7 Global Diabetes Devices and Therapeutics Market Share by Insulin, 2018-2027
9.7.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2018-2027
9.7.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2018-2027
9.7.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2018-2027
9.7.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2018-2027
9.8 Global Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2018-2027
9.8.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2018-2027
9.8.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2018-2027
9.9 Global Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2018-2027
9.9.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2018-2027
9.9.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2018-2027
9.10 Global Diabetes Devices and Therapeutics Market Share by Route of Administration, 2018-2027
9.10.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2018-2027
9.10.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2018-2027
9.10.3 Diabetes Devices and Therapeutics Market Size by Others, 2018-2027
9.11 Global Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2018-2027
9.11.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2018-2027
9.11.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2018-2027
9.12 Global Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2018-2027
9.12.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2018-2027
9.12.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2018-2027
9.12.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2018-2027
9.13 Global Diabetes Devices and Therapeutics Market Share by End User, 2018-2027
9.13.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2018-2027
9.13.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2018-2027
9.13.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2018-2027
Chapter 9 - Chapter 35: This section contains chapters providing diabetes devices and therapeutics market sizing and forecast for additional 20 countries and 5 regions.
Table 1: Diabetes Devices and Therapeutics Financial Deals Market Size and Forecast, by Value (USD Million), 2018-2027
Table 2: Diabetes Devices and Therapeutics Financial Deals Market Size and Forecast, by Volume, 2018-2027
Table 3: Global Diabetes Devices and Therapeutics Market Size by Value (USD MM) 2018-2027
Table 4: Global Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (USD MM), 2018-2027
Table 5: Global Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (USD MM) 2018-2027
Table 6: Global Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027
Table 7: Global Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (USD MM) 2018-2027
Table 8: Global Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (USD MM) 2018-2027
Table 9: Global Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (USD MM) 2018-2027
Table 10: Global Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (USD MM) 2018-2027
Table 11: Global Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027
Table 12: Global Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (USD MM) 2018-2027
Table 13: Global Diabetes Devices and Therapeutics Market Size by Lancets, by Value (USD MM) 2018-2027
Table 14: Global Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (UDS MM) 2018-2027
Table 15: Global Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (UDS MM) 2018-2027
Table 16: Global Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (UDS MM) 2018-2027
Table 17: Global Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (USD MM), 2018-2027
Table 18: Global Diabetes Devices and Therapeutics Market Size by Insulin, by Value (USD MM), 2018-2027
Table 19: Global Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (USD MM), 2018-2027
Table 20: Global Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (USD MM), 2018-2027
Table 21: Global Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (USD MM), 2018-2027
Table 22: Global Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (USD MM), 2018-2027
Table 23: Global Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (USD MM), 2018-2027
Table 24: Global Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (USD MM), 2018-2027
Table 25: Global Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (USD MM), 2018-2027
Table 26: Global Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (USD MM), 2018-2027
Table 27: Global Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (USD MM), 2018-2027
Table 28: Global Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (USD MM), 2018-2027
Table 29: Global Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (USD MM), 2018-2027
Table 30: Global Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (USD MM), 2018-2027
Table 31: Global Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (USD MM), 2018-2027
Table 32: Global Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (USD MM), 2018-2027
Table 33: Global Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (USD MM), 2018-2027
Table 34: Global Diabetes Devices and Therapeutics Market Size by Others, by Value (USD MM), 2018-2027
Table 35: Global Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (USD MM), 2018-2027
Table 36: Global Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (USD MM), 2018-2027
Table 37: Global Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (USD MM), 2018-2027
Table 38: Global Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (USD MM), 2018-2027
Table 39: Global Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (USD MM), 2018-2027
Table 40: Global Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (USD MM), 2018-2027
Table 41: Global Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (USD MM), 2018-2027
Table 42: Global Diabetes Devices and Therapeutics Market Size by Homecare, by Value (USD MM), 2018-2027
Figure 1: BioIntel360 Research Methodology
Figure 2: The History of Diabetes: An Interactive Timeline
Figure 3: List of top diabetes drugs sales in 2020 and expected sales in 2024
Figure 4: Percentage of Diabetics in the Global Adult Population in 2021, 2030, and 2045
Figure 5: Number of Adults (20-79 years) with Diabetes per World Bank Income Classification in 2021 and 2045
Figure 6: Number of People with Diabetes in Adults (20-79 years) by Age Group in 2021 and Estimated Prevalence Across Age Groups in 2045
Figure 7: Top 10 Countries or Territories for Number of Adults (20-79 years) with Diabetes in 2021 and 2045
Figure 8: Total Diabetes-Related Health Expenditure for Adults (20-79 years) with Diabetes from 2006 to 2045
Figure 9: List of Countries or Territories with the Highest Total Health Expenditure (USD Billion) Due to Diabetes (20-79 years) in 2022
Figure 10: Diabetes Prevalence (%) by Regional Distribution in 2021
Figure 11: List of Top Selling FDA Approved Diabetes Drugs
Figure 12: FDA Approved in Diabetes Care From the First Half of 2022
Figure 13: Diabetes Devices and Therapeutics Financial Deals & Alliances Market Size and Forecast, by Value (USD Million), 2018-2027
Figure 14: Diabetes Devices and Therapeutics Financial Deals & Alliances Market Share and Forecast, by Volume (%), 2018-2027
Figure 15: Global Diabetes Devices and Therapeutics: Partnerships Vs Mergers & Acquisition Analysis, 2022 vs 2025
Figure 16: Global Diabetes Devices and Therapeutics Financial Deals: Analysis by Category, 2022 vs 2025
Figure 17: Global Diabetes Devices and Therapeutics Financial Deals: Analysis by Type of Diabetes, 2022 vs 2025
Figure 18: Global Diabetes Devices and Therapeutics Financial Deals: Analysis by Phase-Wise Deals, 2022 vs 2025
Figure 19: Global Diabetes Devices and Therapeutics Financial Deals: Analysis by Type of Industry, 2022 vs 2025
Figure 20: Global Diabetes Devices and Therapeutics Financial Deals: Analysis by Region, 2022 vs 2025
Figure 21: Global Diabetes Devices and Therapeutics Financial Deals: Analysis by Funding Type, 2018-2022
Figure 22: Global Diabetes Devices and Therapeutics Financial Deals: Analysis by Funding Stage, 2018-2022
Figure 23: Diabetes Devices and Therapeutics Financial Deals Total Upfront Cash and Equity, 2018-2022
Figure 24: Recent Deals and Partnership of Diabetes Devices and Therapeutics
Figure 25: Recent Diabetes Devices and Therapeutics Mergers and Acquisitions
Figure 26: Global Diabetes Devices and Therapeutics Deals (> USD 1 Billion) Landscape, 2020-2022
Figure 27: Diabetes Devices and Therapeutics Historic & Futuristics Trends of Patent, by Volume, 2018-2027
Figure 28: Diabetes Devices Historic & Futuristics Trends of Patent, by Volume, 2018-2027
Figure 29: Diabetes Therapeutics Historic & Futuristics Trends of Patent, by Volume, 2018-2027
Figure 30: Diabetes Devices and Therapeutics Patent: Analysis by Type of Diabetes Therapeutics Players, 2022 vs 2025
Figure 31: Diabetes Devices and Therapeutics Patent: Analysis by Type of Diabetes Devices Players, 2022 vs 2025
Figure 32: Diabetes Therapeutics Patent: Analysis by Patent Type, 2018-2022
Figure 33: Diabetes Devices Patent: Analysis by Patent Type, 2018-2022
Figure 34: Diabetes Therapeutics Patent: Analysis by Patent Legal Status, 2018-2022
Figure 35: Diabetes Devices Patent: Analysis by Patent Legal Status, 2018-2022
Figure 36: Diabetes Therapeutics Patent: Analysis by Top Patent Owners, 2022
Figure 37: Diabetes Therapeutics Patent: Analysis by Top Patent Owners, 2022
Figure 38: Diabetes Therapeutics Patent: Analysis by Top Patent Applicants, 2022
Figure 39: Diabetes Therapeutics Patent: Analysis by Top Patent Applicants, 2022
Figure 40: Diabetes Therapeutics Key Patent Applicant: Insulet Corp and CPC Classification Code Analysis., 2022
Figure 41: Diabetes Therapeutics Key Patent Applicant: Albireo Ab and CPC Classification Code Analysis, 2022
Figure 42: Diabetes Therapeutics Key Patent Applicant: Novartis Ag and CPC Classification Code Analysis, 2022
Figure 43: Diabetes Therapeutics Key Patent Applicant: Inst Nat Sante Rech Med and CPC Classification Code Analysis, 2022
Figure 44: Diabetes Therapeutics Key Patent Applicant: Bristol Myers Squibb Co and CPC Classification Code Analysis, 2022
Figure 45: Diabetes Devices Key Patent Applicant: Bigfoot Biomedical INC and CPC Classification Code Analysis, 2022
Figure 46: Diabetes Devices Key Patent Applicant: Hoffmann La Roche and CPC Classification Code Analysis, 2022
Figure 47: Diabetes Devices Key Patent Applicant: Dexcom INC and CPC Classification Code Analysis, 2022
Figure 48: Diabetes Devices Key Patent Applicant: Roche Diabetes Care INC and CPC Classification Code Analysis, 2022
Figure 49: Diabetes Devices Key Patent Applicant: Roche Diabetes Care Gmbh and CPC Classification Code Analysis, 2022
Figure 50: Diabetes Therapeutics Patent: Analysis by Published Status, 2018-2022
Figure 51: Diabetes Devices Patent: Analysis by Published Status, 2018-2022
Figure 52: Diabetes Therapeutics Patent: Analysis by Investors, 2022
Figure 53: Diabetes Devices Patent: Analysis by Investors, 2022
Figure 54: Diabetes Therapeutics Patent: Analysis by CPC Classification Code, 2022
Figure 55: Diabetes Devices Patent: Analysis by CPC Classification Code, 2022
Figure 56: Diabetes Therapeutics Patent: Analysis by Documents by Jurisdiction, 2022
Figure 57: Diabetes Devices Patent: Analysis by Documents by Jurisdiction, 2022
Figure 58: List of Recent Diabetes Therapeutics Patents
Figure 59: List of Recent Diabetes Therapeutics Patents
Figure 60: Diabetes Devices and Therapeutics Clinical Trial Historical and Futuristics Trend, by Volume, 2018-2027
Figure 61: Diabetes Therapeutics Clinical Trial Region-wise Share and Forecast, by Volume (%), 2018-2027
Figure 62: Diabetes Devices Clinical Trial Region-wise Share and Forecast, by Volume (%), 2018-2027
Figure 63: Diabetes Therapeutics Clinical Trial: Analysis by Country-wise
Figure 64: Diabetes Devices Clinical Trial: Analysis by Country-wise
Figure 65: Diabetes Devices and Therapeutics Clinical Trial: Analysis by Age Group
Figure 66: Diabetes Devices and Therapeutics Clinical Trial: Analysis by Funding Agency
Figure 67: Diabetes Devices and Therapeutics Clinical Trial: Analysis by Documents
Figure 68: Diabetes Devices and Therapeutics Clinical Trial: Analysis by Phase-wise
Figure 69: Diabetes Devices and Therapeutics Clinical Trial: Analysis by Status
Figure 70: Diabetes Devices and Therapeutics Clinical Trial: Analysis by Study Type
Figure 71: Diabetes Devices and Therapeutics Companies Competitive Landscape
Figure 72: Diabetes Devices and Therapeutics: Companies by Market Share, 2022
Figure 73: Diabetes Devices and Therapeutics Companies Mapping Quadrant
Figure 74: Diabetes Devices and Therapeutics: Companies by End Users
Figure 75: Diabetes Devices and Therapeutics: Companies by Geography
Figure 76: Diabetes Devices and Therapeutics: Companies by Type of Category
Figure 77: Global Diabetes Devices and Therapeutics Market Size by Value (USD MM) 2018-2027
Figure 78: Global Diabetes Devices and Therapeutics Market Share by Category (%), 2018-2027
Figure 79: Global Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (USD MM), 2018-2027
Figure 80: Global Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (USD MM) 2018-2027
Figure 81: Global Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2018-2027
Figure 82: Global Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027
Figure 83: Global Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (USD MM) 2018-2027
Figure 84: Global Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (USD MM) 2018-2027
Figure 85: Global Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (USD MM) 2018-2027
Figure 86: Global Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2018-2027
Figure 87: Global Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (USD MM) 2018-2027
Figure 88: Global Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (USD MM) 2018-2027
Figure 89: Global Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (USD MM) 2018-2027
Figure 90: Global Diabetes Devices and Therapeutics Market Size by Lancets, by Value (USD MM) 2018-2027
Figure 91: Global Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2018-2027
Figure 92: Global Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (UDS MM) 2018-2027
Figure 93: Global Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (UDS MM) 2018-2027
Figure 94: Global Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (UDS MM) 2018-2027
Figure 95: Global Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2018-2027
Figure 96: Global Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (USD MM), 2018-2027
Figure 97: Global Diabetes Devices and Therapeutics Market Size by Insulin, by Value (USD MM), 2018-2027
Figure 98: Global Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (USD MM), 2018-2027
Figure 99: Global Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (USD MM), 2018-2027
Figure 100: Global Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2018-2027
Figure 101: Global Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (USD MM), 2018-2027
Figure 102: Global Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (USD MM), 2018-2027
Figure 103: Global Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (USD MM), 2018-2027
Figure 104: Global Diabetes Devices and Therapeutics Market Share by Insulin (%), 2018-2027
Figure 105: Global Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (USD MM), 2018-2027
Figure 106: Global Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (USD MM), 2018-2027
Figure 107: Global Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (USD MM), 2018-2027
Figure 108: Global Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (USD MM), 2018-2027
Figure 109: Global Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2018-2027
Figure 110: Global Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (USD MM), 2018-2027
Figure 111: Global Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (USD MM), 2018-2027
Figure 112: Global Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2018-2027
Figure 113: Global Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (USD MM), 2018-2027
Figure 114: Global Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (USD MM), 2018-2027
Figure 115: Global Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2018-2027
Figure 116: Global Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (USD MM), 2018-2027
Figure 117: Global Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (USD MM), 2018-2027
Figure 118: Global Diabetes Devices and Therapeutics Market Size by Others, by Value (USD MM), 2018-2027
Figure 119: Global Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2018-2027
Figure 120: Global Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (USD MM), 2018-2027
Figure 121: Global Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (USD MM), 2018-2027
Figure 122: Global Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2018-2027
Figure 123: Global Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (USD MM), 2018-2027
Figure 124: Global Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (USD MM), 2018-2027
Figure 125: Global Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (USD MM), 2018-2027
Figure 126: Global Diabetes Devices and Therapeutics Market Share by End User (%), 2018-2027
Figure 127: Global Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (USD MM), 2018-2027
Figure 128: Global Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (USD MM), 2018-2027
Figure 129: Global Diabetes Devices and Therapeutics Market Size by Homecare, by Value (USD MM), 2018-2027
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security